UBS OCONNOR LLC - MONTE ROSA THERAPEUTICS INC ownership

MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 53 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of MONTE ROSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$409,440
-40.5%
85,478
-14.9%
0.01%
-54.5%
Q2 2023$688,274
-7.5%
100,478
+5.2%
0.02%
-4.3%
Q1 2023$744,163
-99.9%
95,528
+4.3%
0.02%
+64.3%
Q3 2022$748,000,000
-23.9%
91,615
-9.9%
0.01%0.0%
Q2 2022$983,000,000101,6470.01%
Other shareholders
MONTE ROSA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,472,331$7,052,4652.91%
NEA Management Company, LLC 7,692,298$36,846,1072.85%
Octagon Capital Advisors LP 812,895$3,893,7670.60%
Alphabet Inc. 1,464,015$7,012,6310.45%
Avoro Capital Advisors LLC 4,535,000$21,722,6500.34%
Casdin Capital, LLC 510,882$2,447,1250.27%
Baker Brothers Advisors 4,916,095$23,548,0950.14%
Corton Capital Inc. 14,460$69,2630.04%
ExodusPoint Capital Management, LP 619,248$2,9660.03%
CORNERCAP INVESTMENT COUNSEL INC 27,844$133,3730.02%
View complete list of MONTE ROSA THERAPEUTICS INC shareholders